TME PHARMA NV (ALTME.PA) Stock Analyst Earnings Estimates
EPA:ALTME - Euronext Paris - Matif - NL0015000YE1 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30K | 40K 33.33% | 80K 100.00% | 343.33K -100.00% | N/A | 20.6K | 15.45K -25.00% | 15.45K | ||||||
| EBITDA YoY % growth | -11.79M | -9.9M 16.03% | -5.8M 41.41% | -5.15M 18.97% | N/A 2.13% | -5.116M 12.61% | N/A -43.28% | -14.42M -132.47% | -28.84M 10.96% | -12.36M 60.78% | -4.944M -5.73% | -16.789M -239.58% | -23.793M -41.72% | |
| EBIT YoY % growth | -12.07M | -10.12M 16.16% | -6.14M 39.33% | -4.697M 22.96% | -5.047M 2.33% | 161.37K 11.90% | N/A -43.00% | -14.42M -131.27% | -28.84M 10.74% | -12.36M 59.88% | -5.665M -17.53% | -14.472M -155.45% | -18.849M -30.25% | |
| Operating Margin | -40,233.33% | -25,300.00% | -7,675.00% | -1,368.01% | N/A | N/A | N/A | N/A | N/A | N/A | -27,500.00% | -93,666.67% | -122,000.00% | |
| EPS YoY % growth | N/A | N/A | N/A | -218.36 64.07% | -105.06 51.89% | 91.67 187.25% | -159.65 -274.16% | -26.78 83.23% | -22.54 15.85% | -1.02 95.48% | -0.29 71.21% | -0.48 -64.91% | -0.60 -23.40% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | -90% |
| Revenue | N/A | N/A | 0% | N/A |